ArticleNeoplasia (New York, N.Y.)2009

RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease.

Kilian M Gust et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.